David Gordon, M.B., Ch.B., is Global Head of Clinical Development for the Immunology Therapeutic Area (TA) at Janssen Research & Development, LLC. In this role, he is responsible for implementing and execution of the Development portfolio for Immunology. He will advance the Immunology strategy to develop new and different mechanisms and treatment modalities to help patients achieve immune homeostasis, and ultimately remission from symptoms, across a breadth of immune-mediated diseases.
Prior to his role at Janssen, David served as Chief Medical Officer at Aclaris Therapeutics. Before that, he spent more than 18 years with GlaxoSmithKline where he held a variety of roles, including Clinical Vice President and Medicine Development Leader for their immuno-inflammation and biopharmaceutical groups, and Senior Vice President and Head of Dermatology Research and Development.
David received his medical degree and Bachelor of Medical Biology from the University of Aberdeen in Aberdeen, U.K., and a Diploma in Anaesthetics from the Faculty of The Royal College of Anaesthetists in London. He is accredited as a specialist in pharmaceutical medicine by the Faculty of Pharmaceutical Medicine in London and is a Fellow of the Faculty.
Follow David on LinkedIn here.